David Shaw’s GSK GSK Stock Holding History

David Shaw’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,500	Closed	-$1.95M	–	4604
2022 Q4	$1.95M	Sell	55,500 -52,500	-49%	-$1.75M	﹤0.01%	2962
2022 Q3	$3.18M	Buy	108,000 +68,000	+170%	+$2.58M	﹤0.01%	2575
2022 Q2	$2.18M	Sell	40,000 -32,000	-44%	-$1.77M	﹤0.01%	2992
2022 Q1	$3.92M	Buy	72,000 +16,000	+29%	+$869K	﹤0.01%	2600
2021 Q4	$3.09M	Sell	56,000 -1,200	-2%	-$62.4K	﹤0.01%	2924
2021 Q3	$2.73M	Sell	57,200 -24,000	-30%	-$1.21M	﹤0.01%	2719
2021 Q2	$4.04M	Buy	81,200 +36,480	+82%	+$1.75M	﹤0.01%	2234
2021 Q1	$2M	Buy	44,720 +14,480	+48%	+$657K	﹤0.01%	2589
2020 Q4	$1.39M	Buy	+30,240	New	+$1.39M	﹤0.01%	2804
2017 Q1	–	Sell	-32,000	Closed	-$1.54M	–	3408
2016 Q4	$1.54M	Buy	+32,000	New	+$1.58M	﹤0.01%	2187
2016 Q2	–	Sell	-75,280	Closed	-$3.82M	–	3400
2016 Q1	$3.82M	Hold	75,280	–	–	0.01%	1454
2015 Q4	$3.8M	Buy	+75,280	New	+$3.84M	0.01%	1629

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

David Shaw's GSK Position: Q2 2026 in Review

David Shaw opened a new position in GSK (GSK) in Q2 2026: 1,019,449 shares worth $53.4M. The stake represents 0.03% of the portfolio and ranks #726 among its holdings. This is a return to the name: David Shaw previously reported a position in GSK as recently as Q4 2025.

David Shaw first reported a position in GSK in Q2 2013 and has held it in 30 quarters since. The position peaked at $81.6M in Q2 2015. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

David Shaw held 1,019,449 shares of GSK worth $53.4M as of Q2 2026.
GSK was a new David Shaw position in Q2 2026.
GSK made up 0.03% of David Shaw's portfolio in Q2 2026, its #726 holding.
David Shaw first reported a position in GSK in Q2 2013 and has held it in 30 quarters since.
David Shaw's GSK position peaked at $81.6M in Q2 2015.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.